End-of-day quote
Shanghai S.E.
23:00:00 29/04/2024 BST
|
5-day change
|
1st Jan Change
|
4.31
CNY
|
+1.89%
|
|
+11.95%
|
-13.63%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,102
|
3,225
|
3,163
|
4,687
|
3,320
|
3,395
|
Enterprise Value (EV)
1 |
2,347
|
2,352
|
2,273
|
3,680
|
2,215
|
2,344
|
P/E ratio
|
53.1
x
|
103
x
|
318
x
|
97.6
x
|
67.1
x
|
101
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.24
x
|
4.1
x
|
7.83
x
|
8.26
x
|
5.03
x
|
6.64
x
|
EV / Revenue
|
2.45
x
|
2.99
x
|
5.63
x
|
6.48
x
|
3.36
x
|
4.58
x
|
EV / EBITDA
|
15.7
x
|
28.5
x
|
117
x
|
35.8
x
|
20.4
x
|
32.9
x
|
EV / FCF
|
13.2
x
|
14.3
x
|
90.5
x
|
39.3
x
|
22.9
x
|
18.9
x
|
FCF Yield
|
7.56%
|
6.99%
|
1.11%
|
2.54%
|
4.37%
|
5.29%
|
Price to Book
|
3.18
x
|
3.21
x
|
3.12
x
|
4.42
x
|
2.99
x
|
2.96
x
|
Nbr of stocks (in thousands)
|
680,320
|
680,320
|
680,320
|
680,320
|
680,320
|
680,320
|
Reference price
2 |
4.560
|
4.740
|
4.650
|
6.890
|
4.880
|
4.990
|
Announcement Date
|
12/02/19
|
04/03/20
|
28/04/21
|
27/04/22
|
14/04/23
|
11/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
956.2
|
787.2
|
404
|
567.6
|
659.5
|
511.3
|
EBITDA
1 |
149.5
|
82.37
|
19.45
|
102.8
|
108.7
|
71.27
|
EBIT
1 |
91.61
|
38.01
|
5.004
|
86.67
|
92.49
|
53.94
|
Operating Margin
|
9.58%
|
4.83%
|
1.24%
|
15.27%
|
14.02%
|
10.55%
|
Earnings before Tax (EBT)
1 |
111.2
|
58.34
|
19.35
|
102.4
|
109
|
74.55
|
Net income
1 |
58.36
|
31.25
|
9.926
|
48.05
|
49.47
|
33.58
|
Net margin
|
6.1%
|
3.97%
|
2.46%
|
8.47%
|
7.5%
|
6.57%
|
EPS
2 |
0.0858
|
0.0459
|
0.0146
|
0.0706
|
0.0727
|
0.0494
|
Free Cash Flow
1 |
177.4
|
164.3
|
25.12
|
93.59
|
96.72
|
124
|
FCF margin
|
18.55%
|
20.88%
|
6.22%
|
16.49%
|
14.66%
|
24.25%
|
FCF Conversion (EBITDA)
|
118.68%
|
199.5%
|
129.18%
|
91.05%
|
88.96%
|
173.98%
|
FCF Conversion (Net income)
|
303.99%
|
525.79%
|
253.09%
|
194.76%
|
195.49%
|
369.3%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/02/19
|
04/03/20
|
28/04/21
|
27/04/22
|
14/04/23
|
11/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
755
|
873
|
890
|
1,008
|
1,105
|
1,051
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
177
|
164
|
25.1
|
93.6
|
96.7
|
124
|
ROE (net income / shareholders' equity)
|
9.95%
|
4.96%
|
1.56%
|
8.21%
|
8.37%
|
5.5%
|
ROA (Net income/ Total Assets)
|
4.63%
|
1.89%
|
0.25%
|
4.2%
|
4.22%
|
2.38%
|
Assets
1 |
1,261
|
1,650
|
3,911
|
1,145
|
1,174
|
1,409
|
Book Value Per Share
2 |
1.430
|
1.480
|
1.490
|
1.560
|
1.630
|
1.680
|
Cash Flow per Share
2 |
1.110
|
1.250
|
1.310
|
1.360
|
1.600
|
1.550
|
Capex
1 |
0.06
|
10.1
|
14.4
|
19.7
|
10.8
|
4.98
|
Capex / Sales
|
0.01%
|
1.29%
|
3.57%
|
3.47%
|
1.63%
|
0.97%
|
Announcement Date
|
12/02/19
|
04/03/20
|
28/04/21
|
27/04/22
|
14/04/23
|
11/04/24
|
|
1st Jan change
|
Capi.
|
---|
| -13.63% | 397M | | +4.41% | 103B | | +1.20% | 68.41B | | +44.29% | 39.97B | | +15.99% | 38.97B | | +5.14% | 33.12B | | +5.29% | 19.41B | | +12.32% | 16.73B | | +8.31% | 15.34B | | +17.69% | 15.07B |
Other Commodity Chemicals
|